Many adverse drug reactions (ADRs) are difficult to detect or predict. as they are rare or have a long latency period. They only become apparent after the medicine is released on the market. The primary goal of pharmacovigilance is the early recognition of unexpected ADRs after marketing authorization. https://www.chiggate.com/philadelphia-eagles-mitchell-ness-head-coach-hoodie-sale/